Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4442949
Max Phase: Preclinical
Molecular Formula: C48H48Cl2N6O5
Molecular Weight: 859.85
Molecule Type: Unknown
Associated Items:
ID: ALA4442949
Max Phase: Preclinical
Molecular Formula: C48H48Cl2N6O5
Molecular Weight: 859.85
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOc1cc(C(C)(C)C)ccc1C1=N[C@@H](c2ccc(Cl)cc2)[C@@H](c2ccc(Cl)cc2)N1C(=O)N1CCN(CC#Cc2cccc3c2CN(C2CCC(=O)NC2=O)C3=O)CC1
Standard InChI: InChI=1S/C48H48Cl2N6O5/c1-5-61-40-28-33(48(2,3)4)15-20-37(40)44-52-42(31-11-16-34(49)17-12-31)43(32-13-18-35(50)19-14-32)56(44)47(60)54-26-24-53(25-27-54)23-7-9-30-8-6-10-36-38(30)29-55(46(36)59)39-21-22-41(57)51-45(39)58/h6,8,10-20,28,39,42-43H,5,21-27,29H2,1-4H3,(H,51,57,58)/t39?,42-,43+/m0/s1
Standard InChI Key: SXPSRFOBNYZXKH-UZLVNVLGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 859.85 | Molecular Weight (Monoisotopic): 858.3063 | AlogP: 7.78 | #Rotatable Bonds: 7 |
Polar Surface Area: 114.86 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.61 | CX Basic pKa: 5.52 | CX LogP: 7.93 | CX LogD: 7.92 |
Aromatic Rings: 4 | Heavy Atoms: 61 | QED Weighted: 0.15 | Np Likeness Score: -0.31 |
1. Wang B, Wu S, Liu J, Yang K, Xie H, Tang W.. (2019) Development of selective small molecule MDM2 degraders based on nutlin., 176 [PMID:31128449] [10.1016/j.ejmech.2019.05.046] |
2. Wang B, Liu J, Tandon I, Wu S, Teng P, Liao J, Tang W.. (2021) Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries., 219 [PMID:33862513] [10.1016/j.ejmech.2021.113425] |
Source(1):